Detalles de la búsqueda
1.
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
Ann Hematol
; 102(8): 2233-2240, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392367
2.
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
Ann Hematol
; 100(8): 2051-2059, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33447888
3.
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
Haemophilia
; 27(5): e609-e616, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156738
4.
Erratum: Correction of Affiliations in the Article "Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study".
J Korean Med Sci
; 36(4): e37, 2021 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33496091
5.
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Br J Haematol
; 189(2): 303-312, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012231
6.
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
Ann Hematol
; 99(6): 1283-1291, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333154
7.
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Ann Hematol
; 99(2): 255-264, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897676
8.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Ann Hematol
; 99(2): 309-319, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872360
9.
The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study.
J Korean Med Sci
; 35(47): e401, 2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33289368
10.
Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study.
J Korean Med Sci
; 35(46): e393, 2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33258329
11.
The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients.
Int J Cancer
; 145(9): 2459-2467, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30973963
12.
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
Ann Hematol
; 98(11): 2541-2550, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493002
13.
Correction to: Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.
Support Care Cancer
; 27(10): 3921-3926, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309297
14.
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma.
Br J Haematol
; 202(6): e54-e57, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408333
15.
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2482-2483, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221329
16.
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2274-2284, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056546
17.
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
Ann Hematol
; 97(8): 1437-1443, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29619501
18.
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
Acta Haematol
; 140(3): 146-156, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253397
19.
Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.
Support Care Cancer
; 26(10): 3479-3488, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29682690
20.
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
Am J Hematol
; 92(12): 1280-1286, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28833417